Evidence map›Paper›PMID 42104913›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2026

Homo-/Heterodimeric Substrates Bias the Type and Multiplicity of Hydroxamic Acid Chelators Assembled by a NIS Synthetase DesD.

Callum A Rosser, Todd E Markham, Rachel Codd

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Callum A RosserSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Todd E MarkhamSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Rachel CoddSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Funding

Australian Research Council DP220100101
6 · The paper itself

Abstract

The siderophore synthetase DesD generates hydroxamic acid chelators with applications in metal-based radiopharmaceuticals and sequestering toxic or commodity metals. DesD has been used in chemoenzymatic syntheses with native substrates, with less focus on non-native substrates. This study investigated masking the modest activity of the non-native substrate N-hydroxy-N-glutarylcadaverine (2) by forming a heterodimer with the native DesD substrate N-hydroxy-N-succinylcadaverine (1). Recombinant DesD from Salinispora tropica (StDesD) was evaluated with combinations of homo- and heterodimers of 1 and 2 (3-6) as substrates, including N-to-C positional isomers. Chemoenzymatic reactions using heterodimers of 1 and 2 (5, 6) showed similar substrate consumption and product types to the native 1 homodimer (3), with substrate consumption about three times greater than 2 alone, demonstrating the success of the masking approach. Furthermore, dimeric substrates ablated the ability of StDesD to generate the odd-numbered trimeric hexadentate macrocycle desferrioxamine E (DFOE) as its native major product, instead generating the even-numbered tetrameric macrocycles of dimeric substrates (3, 5, 6) as major products. While the StDesD upper limit of iterations per substrate was similar for monomeric and dimeric substrates, the latter generated chelators with unprecedented cavity sizes and denticities, including an icosadentate chelator that formed a 3:1 metal:ligand complex with Ga(III).

Indexed as

Chelating AgentsHydroxamic AcidsLigasesSiderophoresSubstrate SpecificityChelating AgentsHydroxamic AcidsLigasesSiderophoreschemoenzymatic synthesishydroxamic acidmetal chelatorssiderophore synthetase DesD

Identifiers

PMID42104913
PMCPMC13505702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.